Gauche(+) side-chain orientation as a key factor in the search for an immunogenic peptide mixture leading to a complete fully protective vaccine

Vaccine. 2014 Apr 11;32(18):2117-26. doi: 10.1016/j.vaccine.2014.02.003. Epub 2014 Feb 28.

Abstract

Topological and stereo-electron characteristics are essential in major histocompability class II-peptide-T-cell receptor (MHC-p-TCR) complex formation for inducing an appropriate immune response. Modified high activity binding peptides (mHABPs) were synthesised for complete full protection antimalarial vaccine development producing a large panel of individually fully protection-inducing protein structures (FPIPS) and very high long-lasting antibody-inducing (VHLLAI) mHABPs. Most of those which did not interfere, compete, inhibit or suppress their individual VHLLAI or FPIPS activity contained or displayed a polyproline II-like (PPIIL) structure when mixed. Here we show that amino acid side-chains located in peptide binding region (PBR) positions p3 and p7 displayed specific electron charges and side-chain gauche(+) orientation for interacting with the TCR. Based on the above, and previously described physicochemical principles, non-interfering, long-lasting, full protection-inducing, multi-epitope, multistage, minimal subunit-based chemically synthesised mHABP mixtures can be designed for developing vaccines against diseases scourging humankind, malaria being one of them.

Keywords: Antimalarial vaccine; Gauche(+); Peptide mixtures; Protective immunity; χ(1) angle.

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Amino Acid Sequence
  • Animals
  • Antibodies, Protozoan / blood
  • Antibody Formation
  • Aotus trivirgatus
  • Binding Sites
  • HLA-DR beta-Chains / immunology
  • Malaria Vaccines / chemistry*
  • Malaria, Falciparum / prevention & control
  • Molecular Sequence Data
  • Oligopeptides / chemical synthesis
  • Oligopeptides / immunology*
  • Protein Conformation*

Substances

  • Adjuvants, Immunologic
  • Antibodies, Protozoan
  • HLA-DR beta-Chains
  • Malaria Vaccines
  • Oligopeptides